midazolam has been researched along with Tinnitus in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tinnitus is a phantom auditory perception, which can be induced via application of concentrated sodium salicylate, and is known to be associated with hearing loss and altered neuronal excitability in peripheral and central auditory neurons." | 5.35 | Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. ( Geisler, HS; Hadjab, S; Knipper, M; Köpschall, I; Oestreicher, E; Panford-Walsh, R; Rohbock, K; Rüttiger, L; Singer, W; Tan, J; Vieljans, A; Zimmermann, U, 2008) |
| "Tinnitus is a phantom auditory perception, which can be induced via application of concentrated sodium salicylate, and is known to be associated with hearing loss and altered neuronal excitability in peripheral and central auditory neurons." | 1.35 | Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. ( Geisler, HS; Hadjab, S; Knipper, M; Köpschall, I; Oestreicher, E; Panford-Walsh, R; Rohbock, K; Rüttiger, L; Singer, W; Tan, J; Vieljans, A; Zimmermann, U, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panford-Walsh, R | 1 |
| Singer, W | 1 |
| Rüttiger, L | 1 |
| Hadjab, S | 1 |
| Tan, J | 1 |
| Geisler, HS | 1 |
| Zimmermann, U | 1 |
| Köpschall, I | 1 |
| Rohbock, K | 1 |
| Vieljans, A | 1 |
| Oestreicher, E | 1 |
| Knipper, M | 1 |
1 other study available for midazolam and Tinnitus
| Article | Year |
|---|---|
Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity.
Topics: Animals; Auditory Cortex; Auditory Pathways; Auditory Perception; Behavior, Animal; Brain-Derived Ne | 2008 |